| Title |
|
Established, emerging and future roles of PET/CT in the management of colorectal cancer. |
|
|
| Publication Date |
|
| Author(s) |
|
| Type of document |
|
| DOI |
|
10.1016/j.crad.2008.08.008 |
|
|
| Abstract |
|
Positron-emission tomography-computed tomography (PET/CT) is rapidly being integrated into the imaging pathways of several different tumour types, most frequently using the glucose analogue 2- [(18)F]-fluoro-2-deoxy-D-glucose (FDG). Integrated FDG-PET/CT combines functional and anatomical imaging to improve sensitivity and specificity of tumour detection. The aim of this article is to review the established, emerging, and future roles of FDG-PET/CT in the management of patients with colorectal cancer (CRC). |
|
|
| Link |
|
| Citation |
|
Clinical Radiology 2008; 64(3): 225-37 |
|
|
| Jornal Title |
|